BARUZZI, AGOSTINO
 Distribuzione geografica
Continente #
NA - Nord America 8.347
EU - Europa 6.184
AS - Asia 5.790
AF - Africa 338
SA - Sud America 292
Continente sconosciuto - Info sul continente non disponibili 20
OC - Oceania 10
Totale 20.981
Nazione #
US - Stati Uniti d'America 8.253
CN - Cina 1.548
GB - Regno Unito 1.530
SG - Singapore 1.484
VN - Vietnam 1.426
DE - Germania 1.042
IT - Italia 895
SE - Svezia 640
HK - Hong Kong 505
NL - Olanda 465
UA - Ucraina 355
FR - Francia 335
IN - India 314
RU - Federazione Russa 297
BR - Brasile 219
IE - Irlanda 200
ZA - Sudafrica 119
JP - Giappone 98
EE - Estonia 97
CI - Costa d'Avorio 87
KR - Corea 72
TG - Togo 61
FI - Finlandia 59
CA - Canada 58
JO - Giordania 53
CH - Svizzera 52
BD - Bangladesh 49
AR - Argentina 39
BG - Bulgaria 38
SC - Seychelles 38
AT - Austria 35
UZ - Uzbekistan 32
BE - Belgio 31
PH - Filippine 31
ES - Italia 23
MX - Messico 22
GR - Grecia 20
TR - Turchia 20
IQ - Iraq 17
EU - Europa 16
ID - Indonesia 16
PL - Polonia 16
TH - Thailandia 15
SA - Arabia Saudita 14
IR - Iran 13
RO - Romania 13
TW - Taiwan 13
LB - Libano 12
LT - Lituania 12
MY - Malesia 10
PK - Pakistan 8
DZ - Algeria 7
EC - Ecuador 7
KZ - Kazakistan 7
AU - Australia 6
AZ - Azerbaigian 6
CL - Cile 6
ET - Etiopia 6
PY - Paraguay 6
AE - Emirati Arabi Uniti 5
NG - Nigeria 5
PT - Portogallo 5
VE - Venezuela 5
CO - Colombia 4
DO - Repubblica Dominicana 4
JM - Giamaica 4
NZ - Nuova Zelanda 4
PE - Perù 4
AL - Albania 3
BQ - ???statistics.table.value.countryCode.BQ??? 3
DK - Danimarca 3
IL - Israele 3
KE - Kenya 3
OM - Oman 3
RS - Serbia 3
SN - Senegal 3
SY - Repubblica araba siriana 3
TN - Tunisia 3
CZ - Repubblica Ceca 2
EG - Egitto 2
GT - Guatemala 2
KG - Kirghizistan 2
LV - Lettonia 2
MA - Marocco 2
MC - Monaco 2
MN - Mongolia 2
NP - Nepal 2
PR - Porto Rico 2
PS - Palestinian Territory 2
SI - Slovenia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BO - Bolivia 1
BS - Bahamas 1
CR - Costa Rica 1
GE - Georgia 1
GF - Guiana Francese 1
HR - Croazia 1
Totale 20.972
Città #
Southend 1.306
Singapore 955
Ashburn 943
Fairfield 750
Chandler 643
Hong Kong 467
San Jose 408
Houston 395
Ann Arbor 393
Frankfurt am Main 380
Wilmington 373
Seattle 357
Woodbridge 347
Ho Chi Minh City 341
Eygelshoven 338
Santa Clara 279
Princeton 257
Jacksonville 247
Cambridge 245
Hanoi 241
Boardman 204
Beijing 203
Dublin 195
Dong Ket 193
Hefei 174
Los Angeles 144
Nanjing 129
Padova 120
Westminster 120
Lauterbourg 108
Bologna 106
Abidjan 87
Tokyo 86
Council Bluffs 80
Milan 80
Berlin 75
Jinan 75
Buffalo 74
New York 73
Saint Petersburg 72
Turin 68
Lomé 61
Seoul 59
Helsinki 56
Dallas 55
Shenyang 53
Amman 52
Florence 51
Rome 48
Washington 48
Dearborn 45
Nanchang 44
Haiphong 43
Changsha 42
Medford 41
Da Nang 39
Hebei 39
Guangzhou 38
Sofia 38
Bengaluru 34
Mülheim 34
San Diego 33
Bern 32
Shanghai 32
Tianjin 32
Brussels 31
Mahé 30
São Paulo 29
Phoenix 26
Norwalk 25
Hangzhou 24
London 24
Redwood City 24
Jiaxing 23
Zhengzhou 23
Bremen 22
Redondo Beach 22
San Francisco 21
Toronto 21
Haikou 20
Redmond 20
Can Tho 19
Verona 19
Biên Hòa 18
Des Moines 18
Johannesburg 18
Olalla 18
Yubileyny 17
Chengdu 16
Orem 16
Falkenstein 15
Falls Church 15
Montreal 15
Chicago 14
Vienna 14
Fuzhou 13
Nha Trang 13
Ningbo 13
Düsseldorf 12
Pune 12
Totale 13.860
Nome #
A new potential biomarker for dementia with Lewy bodies 912
Messenger RNA processing is altered in autosomal dominant leukodystrophy 280
Aura uditiva in pazienti con epilessia uditiva 279
Which elderly newly diagnosed glioblastoma patients can benefit from radiotherapy and temozolomide? A PERNO prospective study 275
Autonomic innervation in multiple system atrophy and pure autonomic failure. 274
Genetic polymorphism of catechol-O-methyltransferase and levodopa pharmacokinetic-pharmacodynamic pattern in patients with Parkinson's disease. 269
The effect of a clinically practical exercise on levodopa bioavailability and motor response in patients with Parkinson disease. 266
Clinical features and long term outcome of epilepsy in periventricular nodular heterotopia. Simple compared with plus forms. 261
Expression of 19 microRNAs in glioblastoma and comparison with other brain neoplasia of grades I–III 254
Brain diffusion-weighted imaging in Friedreich's ataxia. 249
Defective Mitochondrial Adenosine Triphosphate Production in Skeletal Muscle From Patients With Dominant Optic Atrophy Due to OPA1 Mutations 245
Sporadic fatal insomnia in a fatal familial insomnia pedigree. 244
Small fiber neuropathy in female patients with fabry disease. 240
Definition of miRNAs expression profile in glioblastoma samples: the relevance of non-neoplastic brain reference. 223
Videopolygraphic and functional MRI study of musicogenic epilepsy. A case report and literature review. 221
Immunoproteasome in cancer and neuropathologies: a new therapeutic target? 221
Generalised anhidrosis: different lesion sites demonstrated by microneurography and skin biopsy. 219
The ND1 gene of complex I is a mutational hot spot for Leber's hereditary optic neuropathy. 216
Loss of temporal retinal nerve fibers in Parkinson disease: a mitochondrial pattern? 214
A new case of Sando syndrome and retinitis pigmentosa with novel combination of compound heterozygous POLG mutations. 211
Mesial temporal lobe epilepsy (MTLE): prognostic factors 210
Anhidrosis in multiple system atrophy: a preganglionic sudomotor dysfunction? 209
Erratum to: Incidence of neuroepithelial primary brain tumors among adult population of Emilia-Romagna Region, Italy 206
Incidence of neuroepithelial primary brain tumors among adult population of Emilia-Romagna Region, Italy 205
BRAF V600E mutation in neocortical posterior temporal epileptogenic gangliogliomas 204
Attività nervosa simpatica ed ipersonnia in pazienti con Sindrome delle Apnee Ostruttive nel Sonno. 200
Endozepines in recurrent stupor. 198
Fattori prognostici in 170 pazienti con epilessia temporale mesiale 198
Idebenone treatment in Leber's hereditary optic neuropathy. 196
Levetiracetam therapeutic monitoring in patients with epilepsy: effect of concomitant antiepileptic drugs. 194
Oncocytic glioblastoma: a glioblastoma showing oncocytic changes and increased mitochondrial DNA copy number 192
A prospective study of direct medical costs in a large cohort of consecutively enrolled patients with refractory epilepsy in Italy 191
The Prognostic Roles of Gender and O6-Methylguanine-DNA Methyltransferase Methylation Status in Glioblastoma Patients: The Female Power 190
Epilepsy in primary cerebral tumors: the characteristics of epilepsy at the onset (results from the PERNO study--Project of Emilia Romagna Region on Neuro-Oncology). 189
Prognostic factors in patients with mesial temporal lobe epilepsy 189
Levetiracetam clinical pharmacokinetics in elderly and very elderly patients with epilepsy 189
Agrypnia Excitata: a microneurographic study of muscle sympathetic nerve activity. 187
Effects of different experimental conditions on the PrPSc core generated by protease digestion: implications for strain typing and molecular classification of CJD. 186
miRNAs expression analysis in paired fresh/frozen and dissected formalin fixed and paraffin embedded glioblastoma using real-time pCR. 185
Severe impairment of Complex I-driven adenosine triphosphate synthesis in leber hereditarfy optic neuropathy cybrids 183
Habituation of sympathetic sudomotor and vasomotor skin responses: neural and non-neural components in healthy subjects. 183
Pre-symptomatic diagnosis in fatal familial insomnia: serial neurophysiological and 18FDG-PET studies 183
Preganglionic sudomotor nerve fiber lesion in a patient with Multiple System Atrophy and generalized anhidrosis. 181
Variation in Lamotrigine Plasma Concentrations with Hormonal Contraceptive Monthly Cycles in Patients with Epilepsy 181
Lateralizing value of the auditory aura in partial seizures. 181
Anidrosi generalizzata: differenti sedi lesionali evidenziate attraverso la biopsia cutanea e la microneurografia. 179
A wide range of 3243A>G/tRNALeu(UUR) (MELAS) mutation loads may segregate in offspring through the female germline bottleneck. 178
Daytime sympathetic hyperactivity in OSAS is related to excessive daytime sleepiness. 176
Unexpected gamma glutamyltransferase rise increase during levetiracetam monotherapy. 175
Un anno di follow-up nei pazienti con epilessia parziale che hanno completato il passaggio da carbamazepina a excarbazepina. 174
Simple and validated HPLC-UV analysis of levetiracetam in deproteinized plasma of patients with epilepsy. 173
Immediate (overnight) switching from carbamazepine to oxcarbazepine monotherapy is equivalent to a progressive switch. 171
Dopamine transporter gene polymorphism, spect imaging, and levodopa response in patients with Parkinson disease. 171
The 13042G>A/ND5 mutation in mtDNA is pathogenic and can be associated also with a prevalent ocular phenotype. 169
Ictal characteristics of psychogenic nonepileptic seizures: what we have learned from video/EEG recordings - a literature review. 169
Effect of deep brain stimulation of the posterior hypothalamic area on the cardiovascular system in chronic cluster headache patients. 168
Effetto della CPAP e della terapia chirurgica sull'attività simpatico muscolare e sulla pressione arteriosa in un paziente con OSAS ed ipertensione. 167
Lacosamide therapeutic monitoring in patients with epilepsy: effect of concomitant antiepileptic drugs. 167
Idiopathic partial epilepsy with auditory features (IPEAF): a clinical and genetic study of 53 sporadic cases. 167
Simultaneous liquid chromatographic determination of lamotrigine, oxcarbazepine monohydroxy derivative and felbamate in plasma of patients with epilepsy 167
Tailored surgery for drug-resistant epilepsy due to temporal pole encephalocele and microdysgenesis. 166
Idebenone treatment in patients with OPA1-mutant dominant optic atrophy. 165
Attività nervosa simpatico muscolare e pressione arteriosa in pazienti Tilt positivi e Tilt negativi con sincope vasovagale. 163
Dominant Optic Atrophy (DOA) and Sensorineural Hearing Loss: Clinical, Biochemical, Spectroscopic and Molecular Genetic Study of a Large Italian Pedigree Linked to a New Locus on Chromosome 16 163
Attività nervosa simpatico muscolare in un paziente affetto da sindrome di Eaton-Lambert ed ipertensione arteriosa. 162
Melanopsin retinal ganglion cell loss in Alzheimer's disease 161
The effect of entacapone on levodopa rate of absorption and latency to motor response in patients with Parkinson disease. 157
Simultaneous HPLC-UV analysis of rufinamide, zonisamide, lamotrigine, oxcarbazepine monohydroxy derivative and felbamate in deproteinized plasma of patients with epilepsy. 157
Progetto Neurooncologia Emilia Romagna - PERNO 156
CPAP treatment lowers sympathetic nerve activity and blood pressure in hypertensive obstructive sleep apnoea patients. 155
Muscle and skin sympathetic activities in Ross syndrome 154
Kinetic-dynamic monitoring of levetiracetam effects in patients with Parkinson disease and levodopa-induced dyskinesias. 153
Extreme variability in genotype/phenotype correlation in an Italian family carrying the mtDNA A3243G/tRNALeu(UUR) MELAS mutation. 153
SPORADIC FATAL INSOMNIA IN A FATAL FAMILIAL INSOMNIA PEDIGREE 152
Focal myoclonus and dystonia associated with celiac disease. 152
Fattori prognostici in 170 pazienti con epilessia temporale mesiale (ETM) 151
Anhidrosis in patients trated with Topiramate. 148
Oxcarbazepine long-term treatment retention in patients switched over from carbamazepine 143
Arousal elicits exaggerated inhibition of sympathetic nerve activity in phobic syncope patients. 143
Esagerata inibizione dell'attività simpatica indotta da stimoli di arousal in pazienti fobici con sincope vasovagale. 141
Lower wake resting sympathetic and cardiovascular activities in narcolepsy with cataplexy. 141
Prognostic factors in patients with Mesial Temporal Lobe Epilepsy (MTLE): A preliminary study. 141
Relationship between adverse effects of antiepileptic drugs, number of coprescribed drugs, and drug load in a large cohort of consecutive patients with drug-refractory epilepsy. 141
Deficit of in vivo mitochondrial ATP production in OPA1-related dominant optic atrophy. 139
"Plus" features of Leber's Hereditary Optic Neuropathy in nineteen Italian families. 139
Polyneuropathy in patients with mitochondrial disorders: clinical, electrophysiological and genetic evaluations. 139
POLG mutations causing ophthalmoplegia, sensorimotor polyneuropathy, ataxia, and deafness. 138
Creutzfeldt-Jakob disease associated with the R208H mutation in the prion protein gene 138
SPARTACUS: underdiagnosis of chronic daily headache in primary care. 138
Il trattamento con CPAP riduce l'attività simpatica e la pressione arteriosa in pazienti con Sindrome delle Apnee Ostruttive nel Sonno ed ipertensione. 136
Prognostic factors in patients with mesial temporal lobe epilepsy (MTLE). 135
Levetiracetam therapy in patients with brain tumour and epilepsy 135
Il monitoraggio terapeutico dei farmaci antiepilettici 133
Corrigendum: Messenger RNA processing is altered in autosomal dominant leukodystrophy [Human Molecular Genetics, 24 (2015) (2746-2756)] DOI:10.1093/hmg/ddv034 132
Polisomnographic and pharmacokinetic findings in levodopa-induced augmentation of restless legs syndrome. 130
Generalised anhidrosis: different lesion sites demonstrated by microneurography and skin biopsy. 130
Microneurographic evaluation of sympathetic activity in small fiber neuropathy. 128
Arousal induces exaggerated inhibition of sympathetic nerve activity in phobic patients with a history of vasovagal syncope. 126
Comparison of levetiracetam and controlled-release carbamazepine in newly diagnosed epilepsy. 125
Myopathy and retinopathy are novel features in a patient with Mohr-Tranebjaerg syndrome. 124
Totale 18.737
Categoria #
all - tutte 53.777
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 53.777


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021467 0 0 0 0 0 0 0 0 0 0 0 467
2021/20222.439 179 81 161 175 198 133 72 130 76 275 539 420
2022/20232.555 260 370 149 313 165 199 79 150 458 59 228 125
2023/2024820 54 122 80 84 100 208 42 41 24 30 10 25
2024/20252.343 73 290 189 184 490 136 163 50 28 159 48 533
2025/20266.334 439 446 496 414 700 683 1.076 168 1.049 417 214 232
Totale 21.269